Advertisement

Insulin Enhancing Effects of Vanadium

  • John H. McNeill
Chapter
  • 23 Downloads

Keywords

Elevated Blood Glucose Vanadium Compound Vanadyl Sulfate Mimetic Effect Obese Nondiabetic Subject 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aguis, L. and Vaartjes, W.J., 1982, The effects of orthovanadate on fatty acid synthesis in isolated rat hepatocytes, Biochem. J.202:791–794.Google Scholar
  2. Aharon, Y., Mevorach, M., and Shamoon, H., 1998, Vanadyl sulfate does not enhance insulin action in type 1 diabetes, Diabetes Care21:2194.PubMedGoogle Scholar
  3. Battell, M.L., Yuen, V.G., and McNeill, J.H., 1992, Treatment of BB rats with vanadyl sulfate, Pharmacol. Commun.1:291–301.Google Scholar
  4. Brichard, S.M., Okitolonda, W., and Henquin, J.C., 1988, Long-term improvement of glucose homeostasis by vanadate treatment in diabetic rats, Endocrinology123:2048–2053.PubMedGoogle Scholar
  5. Bruck, R., Prigozin, H., Krepel, Z., Rotenberg, P., Shechter, Y., and Bar-Meir, S., 1991, Vanadate inhibits glucose output from isolated perfused rat liver, Hepatology14:540–544.PubMedGoogle Scholar
  6. Byrne, A.R. and Kosta, L., 1978, Vanadium in foods and in human body fluids and tissues, Sci. Total Environ.10:17–30.PubMedGoogle Scholar
  7. Byrne, A.R. and Kosta, L., 1979, On the vanadium and tin contents of diet and human blood, Sci. Total Environ.13:87–90.PubMedGoogle Scholar
  8. Cantley, L.C.Jr., Josephson, L., Warner, R., Yanagisawa, M., Lechend, C., and Guidotti, G., 1977, Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle, J. Biol. Chem.252:7421–7423.PubMedGoogle Scholar
  9. Chasteen, N. Dennis (Ed), 1990, Vanadium in Biological Systems: physiology and biochemistry, Kluwer Academic Publishers, Boston, 225pp.Google Scholar
  10. Clark, A.S., Fagan, J.M., and Mitch, W.E., 1985, Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle, Biochem. J.232:273–276.PubMedPubMedCentralGoogle Scholar
  11. Clausen, T., Andersen, T.L., Sturup-Johansen, M., and Perkova, O., 1981, The relationship between the transport of glucose and cations across cell membranes in isolated tissues. XI. The effect of vanadate on 45Ca-efflux and sugar transport in adipose tissue and skeletal muscle, Biochim. Biophys. Acta646:261–267.PubMedGoogle Scholar
  12. Cornelis, R., Versieck, J., Mees, L., Hoste, J., and Barbier, F., 1981, The ultra trace element vanadium in human serum, Biol. Trace Elem. Res.3:257–263.Google Scholar
  13. Curran, G.L., Azarnoff, D.L., and Bolinger, R.E., 1959, Effect of cholesterol synthesis inhibition in normocholesterolemic young men, J. Clin. Invest.38:1251–1261.PubMedPubMedCentralGoogle Scholar
  14. Degani, H., Gochin, M., Karlish, S.J.D., and Shechter, Y., 1981, Electron paramagnetic resonance studies and insulin-like effects of vanadium in rat adipocytes, Biochemistry20:5795–5799.PubMedGoogle Scholar
  15. Domingo, J.L., Gomez, M., Sanchez, D.J., Llobet, J.M., and Keen, C.L., 1995, Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation, Mol. Cell. Biochem.153:233–240.PubMedGoogle Scholar
  16. Duckworth, W.C., Solomon, S.S., Liepnieks, J., Hamel, F.G., Hand, S., and Peavy, D.E., 1988, Insulin-like effects of vanadate in isolated rat adipocytes, Endocrinology122:2285–2289.PubMedGoogle Scholar
  17. Fantus, I.G., Kadota, S., Deragon, G., Foster, B., and Posner, B.I., 1989, Pervanadate [Peroxide(s) of vandate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase, Biochemistry28:8864–8871.PubMedGoogle Scholar
  18. Goldfine, A.B., Willsky, G., and Kahn, C.R., 1998, Vanadium salts in the treatment of human diabetes In: Vanadium Compounds: chemistry, biochemistry and therapeutic applications, Amer. Chem. Soc. p. 353–368.Google Scholar
  19. Gomez-Foix, a.M., Rodriguez-Gil, J.E., Fillat, C., Guinovart, J.J., and Bosch, F., 1988, Vanadate raises fructose 2,6-bisphosphate concentrations and activates glycolysis in rat hepatocytes, Biochem. J.255:507–512.PubMedPubMedCentralGoogle Scholar
  20. Guzman, M. and Castro, J., 1990, Simultaneous stimulation of fatty acid synthesis and oxidation in rat hepatocytes by vanadate, Arch. Biochem. Biophys.283:90–95.PubMedGoogle Scholar
  21. Halberstram, M., Cohen, N., Schlimovich, P., Rossetti, L., and Shamoon, H., 1996, Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects, Diabetes45:659–666.Google Scholar
  22. Heyliger, C.E., Tahiliani, A.G., and McNeill, J.H., 1985, Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats, Science227:1474–1477.PubMedGoogle Scholar
  23. Hudson, T.O.F., 1964, Vanadium: Toxicology and biological significance, Elsevier Publishing Co., Amsterdam.Google Scholar
  24. Jackson, T.K., Salhanick, A.I., Sparks, J.D., Sparks, C.E., Bolognino, M., and Amatruda, J.M., 1988, Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes, Diabetes37:1234–40.PubMedGoogle Scholar
  25. Leonard, A. and Gerber, G.B., 1998, Mutangenicity, carcinogenicity and teratogenicity of vanadium, In: Vanadium in the Environment, Part Two: Health effects, John Wiley & Sons, New York, p. 39–53.Google Scholar
  26. Lyonnet, Martz, and Martin, 1899, Líemploi therapeutique des derives du vanadium, La Presse Medicale, April 22, p. 191–192.Google Scholar
  27. McNeill, J.H., Yuen, V.G., Hoveyda, H.R., and Orvig, C., 1992, Bis(maltolato)oxovanadium(iv) is a potent insulin mimic, J. Med. Chem.325:1489–1491.Google Scholar
  28. Meyerovitch, J., Farfel, Z., Sack, J., and Shechter, Y, 1987, Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats, J. Biol. Chem.262:6658–6662.PubMedGoogle Scholar
  29. Mountjoy, K.G. and Flier, J.S., 1990, Vanadate regulates glucose transporter (Glut-1) expression in NIH 3T3 mouse fibroblasts, Endocrinology127:2025–2034.PubMedGoogle Scholar
  30. Nechay, B.R., Nanninga, L.B., Nechay, P.S., Post, R.L., Grantham, J.J., Macara, I.G., Kubena, L.F., Phillips, T.D., and Nielsen, F.H., 1986, Role of vanadium in biology, Feb. Proc.45:123–132.Google Scholar
  31. Nriagu, J.O. (Ed), 1998, Vanadium in the Environment, Part Two: Health effects, John Wiley & Sons, New York, 401pp.Google Scholar
  32. Orvig, C., Thompson, K.H., Battell, M., and McNeill, J.H., 1995, Vanadium compounds as insulin mimics, In: Metal Ions in Biological Systems (H Sigel and A Sigel, Eds), Marcel Dekker, Inc, Basel, V. 31, Chapter 17:575–594.Google Scholar
  33. Paquet, M.R., Romanek, R.J., and Sargeant, R.J., 1992, Vanadate induces the recruitment of GLUT-4 glucose transporter to the plasma membrane of rat adipocytes, Mol. Cell. Biochem.109:149–155.PubMedGoogle Scholar
  34. Poucheret, P., Verma, S., Grynpas, M.C., and McNeill, J.H. 1998, Vanadium and diabetes, Mol. Cell. Biochem.188:73–80.PubMedGoogle Scholar
  35. Ramanadham, S., Brownsey, R.W., Cros, G.H., Mongold, J.J., and McNeill, J.H., 1989b, Sustained preventions of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment, Metabolism38:1022–1028.PubMedGoogle Scholar
  36. Ramanadham, S., Mongold, J.J., Brownsey, R.W., Cros, G.H., and McNeill, J.H., 1989a, Oral vanadyl sulfate in treatment of diabetes mellitus in rats, Am. J. Physiol.257:H904–H911.PubMedGoogle Scholar
  37. Sakurai, H., Fujii, K., Fujimoto, S., Fujisawa, Y., Takechi, K., and Yasui, H., 1998, Structure-activity relationship of insulin-mimetic vanadyl complexes with VO(N202) Coordination Mode, In: Vanadium Compounds: chemistry, biochemistry and therapeutic applications (Tracey, A.S. and Crans, D.C., Ed), Amer. Chem. Soc. p. 344–352.Google Scholar
  38. Shechter, Y., 1990, Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes, Diabetes39:1–5.PubMedGoogle Scholar
  39. Shechter, Y and Ron, A., 1986, Effect of depletion of phosphate and bicarbonate ions on insulin action in rat adipocytes, J. Biol. Chem.261:14945–14950.PubMedGoogle Scholar
  40. Sigel, H. and Sigel, A. (Ed), 1995, Metal Ions in Biological Systems 31: Vanadium and its role in life, Marcel Dekker Inc, New York, 779pp.Google Scholar
  41. Simonoff, M., Llabador, Y., Peers, A.M., and Simonoff, G.N., 1984, Vanadium in human serum, as determined by neutron activation analysis, Clin. Chem.30:1700–1703.PubMedGoogle Scholar
  42. Srivastiva, A.K., 1995, Potential use of vanadium compounds in the treatment of diabetes mellitus, Exp. Opin. Invest. Drugs4(6):525–536.Google Scholar
  43. Srivastiva, A.K. and Chiasson, J.L. (Ed), 1995, Vanadium Compounds: Biochemical and therapeutic applications, Mol. Cell, Biochem.153:1–244.Google Scholar
  44. Tamura, S., Brown, T.A., Dubler, R.E., and Larner, J., 1983, Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 dalton subunit of insulin receptor, Biochem. Biophys. Res. Commun.113:80–86.PubMedGoogle Scholar
  45. Thompson, K.H., Battell, M., and McNeill, J.H., 1998, Toxicology of vanadium in mammals, In: Vanadium in the Environment, John Wiley and Sons, New York Chap. 31, p. 21–38.Google Scholar
  46. Thompson, K.H., Yuen, V.G., McNeill, J.H., and Orvig, C., 1998, Chemical and pharmacological studies of a new class of antidiabetic vanadium complexes, In: Vanadium Compounds: chemistry, biochemistry and therapeutic applications (Tracey, A.S. and Crans, D.C., Ed), Amer. Chem. Soc. p. 329–343.Google Scholar
  47. Tolman, E.L., Barris, E., Burns, M., Pansisni, A., and Partridge, R., 1979, Effects of vanadium on glucose metabolism inn vitro, Life Sci.25:1159–1164.PubMedGoogle Scholar
  48. Tracey, A.S. and Crans, D.C. (Ed), 1998, Vanadium Compounds: chemistry, biochemistry and therapeutic applications, Amer. Chem. Soc. 381pp.Google Scholar
  49. Tsiani, E. and Fantus, G., 1997, Vanadium Compounds: Biological actions and potential as pharmacological agents, Trends Endocrinol. Metab.8:51–58.PubMedGoogle Scholar
  50. Ueki, H., Sera, M., and Tanaka, K., 1989, Stimulatory release of lipoprotein lipase activity from rat fat pads by vanadate, Arch. Biochem. Biophys.272:18–24.PubMedGoogle Scholar
  51. Ueki, H., Sera, M., Tominaga, N., Morita, T., Sugino, E., and Hibino, S., 1992, Inhibition of increasing effect of vanadate on glycogen content and lipoprotein lipase activity in fat pads by 5-N,N-hexamethylene amiloride, Chem. Pharm. Bull.40:542–543.PubMedGoogle Scholar
  52. Verma, S., Cam, M.C., and McNeill, J.H., 1998, Nutritional factors that can favorably influence the glucose/insulin system: vanadiumî. J. Amer. Col. Nutrition17(1):11–18.Google Scholar
  53. Waters, M.D., 1977, Toxicology of vanadium, In: Advances in Modern Toxicology, Vol. 2, Toxicology of Trace Elements, (Goyer RA, Mehlman MA, Ed), Hemisphere, Washington, D.C. pp. 147–189.Google Scholar
  54. Yuen, V.G., Pederson, R.A., Dai, S., Orvig, C., and McNeill, J.H., 1996, Effects of low and high dose administration of bis(maltolato)oxovanadium(iv) on fa/fa Zucker rats, Can. J. Physiol. Pharmacol.74: 1001–1009.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • John H. McNeill
    • 1
  1. 1.Faculty of Pharmaceutical SciencesThe University of British ColumbiaVancouverCanada

Personalised recommendations